Remove Angioplasty Remove Hypertension Remove Outcomes
article thumbnail

Chronic Thromboembolic Pulmonary Hypertension: the therapeutic assessment

Frontiers in Cardiovascular Medicine

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.

article thumbnail

Durable versus biodegradable polymer drug-eluting stents in all-comers

Open Heart

Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. We aimed to compare outcomes between a broad range of second-generation DP-DES and BP-DES in an all-comer population. Conclusion Clinical follow-up up to 2 years shows similar outcomes between BP-DES and DP-DES.

Stents 52
article thumbnail

Medtronic Presents New Data, Clinical Milestones at CRT 2025

DAIC

Sacharias von Kochpresented " Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons" This is atwo-year analysis from the Swedish Coronary Angiography and Angioplasty (SCAAR) Registry in more than 6,000 patients. This study is a pooled analysis from the U.S.

article thumbnail

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Open Heart

Background The treatment of pulmonary hypertension (PH) has improved rapidly in recent decades. There is increasing evidence to support the role of early intervention and treatment in affecting clinical outcomes in PH. Specifically, changes in heart rate variability (HRV), heart rate (HR) and physical activity were assessed.

article thumbnail

Abstract 215: A Sweet Indicator: HbA1C and Thrombectomy Outcomes in Hispanics

Stroke: Vascular and Interventional Neurology

Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. Patients with poorly controlled diabetes also were more likely to require angioplasty (31.3% or greater. vs 72, p<0.001) compared to patients who did not have poorly controlled diabetes.

article thumbnail

Abstract WMP94: Trends in Co-morbidities and Mortality in Rescue Stenting and Elective Stenting for Intracranial Atherosclerotic Disease: National Inpatient Sample Data Analysis

Stroke Journal

National Inpatient Sample (NIS) database from 2009 to 2020, evaluating patients who presented with stroke from ICAD and were treated with angioplasty and stenting and analyzed presenting co-morbidities and patient outcomes. There were significantly higher incidences in uncontrolled hypertension (28.2% vs 7.9%), diabetes (33.6%

Stent 40
article thumbnail

Medtronic Presents New Data, Clinical Milestones

DAIC

Sacharias von Kochpresented " Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons" This is atwo-year analysis from the Swedish Coronary Angiography and Angioplasty (SCAAR) Registry in more than 6,000 patients. This study is a pooled analysis from the U.S.